ConnectedHeartHealth - Heart Failure Readmission Intervention

Completed · Not applicable

Conditions studied: Diabetes Mellitus, Coronary Artery Disease, Heart Failure

In brief

This is a single-center, pilot study that will evaluate the effectiveness of the AHA science based CarePlans and the Ambio Health technology in improving the risk adjusted 30 day readmissions rate, patient compliance, and biometrics. The study will also be used to assess the feasibility of similar heart failure transition programs in the future.

Key facts

Study ID

NCT03247608

Run by

LifeBridge Health

People needed

30

Starts

2015-11-01

Expected to finish

2017-10-09

Last updated by the study team

2019-03-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Has a diagnosis of Heart Failure as measured by the New York Heart Association (NYHA) functional classification and is currently in functional class II- IV status.
• Have been hospitalized for an episode of acute HF decompensation within the last 30 days.
• Have access to the internet.
• Are physically and mentally capable to complete the monitoring process or have a caregiver capable of assisting in the use of the Ambio Health system.
• Willing and able to sign an informed consent form to participate in this evaluation for a duration of 180 days.

You may not qualify if…

• Have a life expectancy of less than six months.
• Live in a nursing home other multi-member assisted living facility
• Intend to be away from their home for more than 2 weeks (14 days) total during the monitoring period.
• Are unable to read English at a minimum 5th grade level

Where it is running

• Sinai Hospital of Baltimore — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.